Mayo Clinic Proceedings Home

Artificial Intelligence ECG to Detect Left Ventricular Dysfunction in COVID-19

A Case Series
Published:September 19, 2020DOI:


      Coronavirus disease 2019 (COVID-19) can result in deterioration of cardiac function, which is associated with high mortality. A simple point-of-care diagnostic test to screen for ventricular dysfunction would be clinically useful to guide management. We sought to review the clinical experience with an artificial intelligence electrocardiogram (AI ECG) to screen for ventricular dysfunction in patients with documented COVID-19. We examined all patients in the Mayo Clinic system who underwent clinically indicated electrocardiography and echocardiography within 2 weeks following a positive COVID-19 test and had permitted use of their data for research were included. Of the 27 patients who met the inclusion criteria, one had a history of normal ventricular function who developed COVID-19 myocarditis with rapid clinical decline. The initial AI ECG in this patient indicated normal ventricular function. Repeat AI ECG showed a probability of ejection fraction (EF) less than or equal to 40% of 90.2%, corroborated with an echocardiographic EF of 35%. One other patient had a pre-existing EF less than or equal to 40%, accurately detected by the algorithm before and after COVID-19 diagnosis, and another was found to have a low EF by AI ECG and echocardiography with the COVID-19 diagnosis. The area under the curve for detection of EF less than or equal to 40% was 0.95. This case series suggests that the AI ECG, previously shown to detect ventricular dysfunction in a large general population, may be useful as a screening tool for the detection of cardiac dysfunction in patients with COVID-19.
      To read this article in full you will need to make a payment


      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hu H.
        • Ma F.
        • Wei X.
        • Fang Y.
        Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin.
        Eur Heart J. 2020;
        • Inciardi R.M.
        • Lupi L.
        • Zaccone G.
        • et al.
        Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19).
        JAMA Cardiol. 2020; 5: 819-824
        • Shi S.
        • Qin M.
        • Shen B.
        • et al.
        Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China.
        JAMA Cardiol. 2020; 5: 802-810
        • Wang D.
        • Hu B.
        • Hu C.
        • et al.
        Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.
        JAMA. 2020; 323: 1061-1069
        • Bangalore S.
        • Sharma A.
        • Slotwiner A.
        • et al.
        ST-segment elevation in patients with COVID-19 — a case series.
        N Engl J Med. 2020; 382: 2478-2480
        • Attia Z.I.
        • Kapa S.
        • Lopez-Jimenez F.
        • et al.
        Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram.
        Nat Med. 2019; 25: 70-74
        • Yasin O.Z.
        • Attia Z.
        • Dillon J.J.
        • et al.
        Noninvasive blood potassium measurement using signal-processed, single-lead ecg acquired from a handheld smartphone.
        J Electrocardiol. 2017; 50: 620-625
        • Noseworthy P.A.
        • Attia Z.I.
        • Brewer L.C.
        • et al.
        Assessing and mitigating bias in medical artificial intelligence: the effects of race and ethnicity on a deep learning model for ECG analysis.
        Circ Arrhythm Electrophysiol. 2020; 13: e007988
        • Attia Z.I.
        • Noseworthy P.A.
        • Lopez-Jimenez F.
        • et al.
        An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction.
        Lancet. 2019; 394: 861-867
        • Ko W.Y.
        • Siontis K.C.
        • Attia Z.I.
        • et al.
        Detection of hypertrophic cardiomyopathy using a convolutional neural network-enabled electrocardiogram.
        J Am Coll Cardiol. 2020; 75: 722-733